Subscribe

Americas

Why AI is changing the patent rules faster than anyone can keep up
Why AI is changing the patent rules faster than anyone can keep up
24 October 2025   A panel of experts at LSPN shared how AI is forcing companies to rethink everything from obviousness arguments to the choice between patents and trade secrets, and why the claims filed today may be invalid tomorrow.
Is AI emerging as the ‘fourth party’ solving billion-dollar disputes?
23 October 2025
The hidden code in life sciences deals
23 October 2025
Less is more: patent lawyers flip the script after Amgen
22 October 2025
‘Doing more with less’: In-house counsel on budgets and strategy
22 October 2025
End of the ‘Death Squad’? Squires puts PTAB on trial
22 October 2025
Data and delivery: Inside AI's inventorship dilemma
21 October 2025
All news

Latest Features

Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
In the second of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax delve into the real reasons why medicine costs more in the US.
Americas
Startup CFO’s betrayal is a lesson in preparing for the worst
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Americas
‘Masking only works for so long’: Working with ADHD
Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones.
Americas
Second chances: Brazil’s bid to revitalise the country’s healthcare system
Brazil’s updated regulations for its flagship partnerships programme marks a renewed effort to strengthen the nation's health sector, says Rob Rodrigues of RNA Law.
Americas
Patent term compensation controversies in Mexico
An ambiguous decision by the Supreme Court has paved the way for frivolous petitions for compensation and clarity is needed, say Daniel Sanchez and Karla Olvera of Olivares.
Americas
How to patent biological materials from 3D printing
Securing IP protection in Brazil for the ‘bio-ink’ used to print new human tissue has challenges but composition is key, say Priscila Kashiwabara and Breno Souza of Kasznar Leonardos.
Americas
Is the ITC the right venue for trade secrets theft?
If the right steps are taken, the US International Trade Commission is an attractive option for firms fearing the loss of their valuable IP, say Mary Prendergast, Mark Whitaker and Nicole Ang of Morrison Foerster.
Americas
'Cellect': why patent term adjustment is ripe for review
In part 2 of articles assessing the impact of 'Cellect v Samsung', Vincent Shier of Haynes Boone now sets out what the future may hold—both for this unusual case, as well as judicial doctrine in general.
All features


More News

Top pharma, biotech, and medtech experts gather at LSPN Fall
21 October 2025   LSIPR is gearing up for the 5th annual LSPN North America Fall Conference, starting October 21, in San Francisco, California.
Mitsubishi Tanabe doubles down on Radicava protection
20 October 2025   The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment.
‘All it takes is a post on Truth Social’: Is this patent reform's moment?
17 October 2025   A US Senate subcommittee hearing on patent eligibility reform has David Kappos, former USPTO director, believing that “there’s a better chance than ever” of a pending bill becoming law, finds Sarah Speight.
Protect early, partner wisely: In-house tips for medtech startups
15 October 2025   In-house IP director at RefleXion talks about protecting complex medtech, why startups can't afford to cut corners on early decisions, and when to employ outside expertise.
Gilead blocks HIV drug generics for more than 10 years
9 October 2025   The pharma giant extends market exclusivity for a top-selling drug accounting for nearly half of its multi-billion-dollar sales.
Eli Lilly strikes AI drug discovery deal with US biotech
7 October 2025   The pharma giant will share rights to new innovations with an AI-driven organoid platform designed to produce fully human antibodies in weeks.
ITC probes on the rise, but gender parity lags behind
3 October 2025   A spike in agency investigations and more female lead counsel still leave a notable gender gap at the venue, find Troutman Pepper Locke’s Emma Mann, Gwendolyn Tawresey, Brittany Reeves, and Gillian Schutt.
More news